Shanghai Hile Bio-tech (SHG:603718) — Stock Price
Shanghai Hile Bio-tech (SHG:603718) is currently trading at CN¥3.07 CNY, up 0.00% today. Over the past 52 weeks, shares have ranged between CN¥2.61 and CN¥7.20. This page tracks Shanghai Hile Bio-tech's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 603718 company net worth.
Shanghai Hile Bio-tech (603718) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Shanghai Hile Bio-tech's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.
Shanghai Hile Bio-tech Income Statement — Revenue, Profit & Earnings by Year
Shanghai Hile Bio-tech's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥187.87 Million | CN¥271.04 Million | CN¥240.72 Million | CN¥299.99 Million | CN¥347.29 Million |
| Cost of Revenue | CN¥52.28 Million | CN¥110.39 Million | CN¥120.30 Million | CN¥124.61 Million | CN¥158.40 Million |
| Gross Profit | CN¥135.59 Million | CN¥160.65 Million | CN¥120.42 Million | CN¥175.38 Million | CN¥188.89 Million |
| Research & Development | CN¥22.67 Million | CN¥32.79 Million | CN¥24.97 Million | CN¥29.94 Million | CN¥28.64 Million |
| SG&A | CN¥16.78 Million | CN¥62.62 Million | CN¥58.94 Million | CN¥69.11 Million | CN¥50.44 Million |
| Total Operating Expenses | CN¥140.80 Million | CN¥-13.88 Million | CN¥65.25 Million | CN¥105.46 Million | CN¥131.65 Million |
| Operating Income | CN¥47.07 Million | CN¥174.53 Million | CN¥55.17 Million | CN¥69.92 Million | CN¥57.24 Million |
| EBITDA | — | CN¥248.35 Million | CN¥97.07 Million | CN¥182.70 Million | CN¥126.56 Million |
| EBIT | — | CN¥213.61 Million | CN¥61.41 Million | CN¥141.53 Million | CN¥69.66 Million |
| Interest Expense | CN¥1.26 Million | CN¥5.49 Million | CN¥5.39 Million | CN¥10.31 Million | CN¥12.53 Million |
| Income Before Tax | CN¥-184.82 Million | CN¥208.12 Million | CN¥56.02 Million | CN¥131.22 Million | CN¥57.14 Million |
| Income Tax Expense | — | CN¥26.48 Million | CN¥6.01 Million | CN¥20.53 Million | CN¥11.47 Million |
| Net Income | CN¥-311.44 Million | CN¥171.18 Million | CN¥62.87 Million | CN¥121.61 Million | CN¥53.86 Million |
Shanghai Hile Bio-tech Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Shanghai Hile Bio-tech's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥1.13 Billion | CN¥1.83 Billion | CN¥1.66 Billion | CN¥1.51 Billion | CN¥1.84 Billion |
| Total Current Assets | CN¥595.84 Million | CN¥691.77 Million | CN¥562.55 Million | CN¥665.03 Million | CN¥975.44 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥210.84 Million | CN¥158.58 Million | CN¥212.48 Million | CN¥236.15 Million | CN¥385.59 Million |
| Net Receivables | CN¥100.85 Million | CN¥111.89 Million | CN¥89.86 Million | CN¥97.41 Million | CN¥121.37 Million |
| Inventory | CN¥59.46 Million | CN¥55.01 Million | CN¥102.82 Million | CN¥144.89 Million | CN¥142.62 Million |
| Property, Plant & Equipment | — | — | — | CN¥219.45 Million | CN¥275.90 Million |
| Goodwill | CN¥381.82 Million | CN¥1.01 Billion | CN¥225.33 Million | CN¥224.14 Million | CN¥224.14 Million |
| Total Liabilities | CN¥229.14 Million | CN¥123.65 Million | CN¥482.96 Million | CN¥403.25 Million | CN¥856.90 Million |
| Total Current Liabilities | CN¥111.54 Million | CN¥100.25 Million | CN¥417.04 Million | CN¥320.75 Million | CN¥669.96 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | CN¥-309.16 Million | CN¥-89.91 Million | CN¥-115.34 Million | CN¥-138.41 Million |
| Total Stockholder Equity | CN¥882.04 Million | CN¥1.56 Billion | CN¥1.22 Billion | CN¥1.14 Billion | CN¥1.01 Billion |
| Retained Earnings | CN¥28.29 Million | CN¥556.71 Million | CN¥309.13 Million | CN¥289.07 Million | CN¥179.62 Million |
Shanghai Hile Bio-tech Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Shanghai Hile Bio-tech generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥58.83 Million | CN¥46.47 Million | CN¥-2.94 Million | CN¥292.91 Million | CN¥43.63 Million |
| Capital Expenditures | CN¥12.17 Million | CN¥8.39 Million | CN¥7.81 Million | CN¥19.85 Million | CN¥37.78 Million |
| Free Cash Flow | CN¥46.66 Million | CN¥38.08 Million | CN¥-16.18 Million | CN¥273.06 Million | CN¥5.85 Million |
| Investing Cash Flow | — | CN¥38.34 Million | CN¥-171.09 Million | CN¥66.13 Million | CN¥41.54 Million |
| Financing Cash Flow | — | CN¥126.29 Million | CN¥159.99 Million | CN¥-355.53 Million | CN¥50.01 Million |
| Dividends Paid | CN¥122.26 Million | CN¥21.57 Million | CN¥36.51 Million | CN¥683.94K | CN¥2.70 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥17.88 Million | CN¥39.26 Million | CN¥40.87 Million | CN¥47.37 Million | CN¥57.57 Million |
| Change in Cash | CN¥-146.84 Million | CN¥221.41 Million | CN¥-19.46 Million | CN¥3.52 Million | CN¥135.18 Million |
Shanghai Hile Bio-tech Earnings History — EPS Actual vs. Analyst Estimates
Track Shanghai Hile Bio-tech's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 23, 2025 | — | — | — |
| Apr 29, 2023 | 0.02 | — | — |
| Oct 29, 2022 | 0.02 | — | — |
| Aug 30, 2022 | 0.03 | — | — |
| Apr 29, 2022 | 0.03 | — | — |
| Oct 29, 2021 | 0.02 | — | — |
| Sep 02, 2021 | 0.02 | — | — |
| Apr 24, 2021 | 0.02 | — | — |